Notice2021-26676
Bulk Manufacturer of Controlled Substances Application: Noramco Coventry LLC
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 9, 2021
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Noramco Coventry LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 234 (Thursday, December 9, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 234 (Thursday, December 9, 2021)]
[Notices]
[Page 70148]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-26676]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-928]
Bulk Manufacturer of Controlled Substances Application: Noramco
Coventry LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Noramco Coventry LLC, has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before February 7,
2022. Such persons may also file a written request for a hearing on the
application on or before February 7, 2022.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 29, 2021, Noramco Coventry LLC, 498
Washington Street, Coventry, Rhode Island 02816, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dihydromorphine........................ 9145 I
Methylphenidate........................ 1724 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Levorphanol............................ 9220 II
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for use as intermediates and converted to other controlled
substances or for sale to its customers. In reference to drug codes
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans
to bulk manufacture these drugs as synthetics. No other activities for
these drug codes are authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26676 Filed 12-8-21; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on December 9, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.